Bionomics Limited (BNOX)

Name: Bionomics Limited Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-09-30

Latest Quarter

2025-09-30

Revenue

$0.0

Net Income

-$15.0M

Operating Margin

N/A

Free Cash Flow

$77.2M

Debt / Assets

33.5%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Bionomics Limited (BNOX).
Income Statement (Quarterly)	2025-09-30	2025-03-31	2024-12-31	2024-09-30
Revenue	0	15,000,000	662,715	0
Cost of Revenue	250,826	0	0	0
Gross Profit	-250,826	0	662,715	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	2,573,818	1,407,000	2,629,000	1,667,000
Operating Expenses	8,301,126	3,023,000	4,366,000	3,568,000
Operating Income	-8,551,953	11,977,000	-3,704,000	-3,568,000
Interest Expense	0	0	0	0
Income Before Tax	-15,040,188	11,181,000	-1,932,000	-937,000
Income Tax Expense	-52,638	81,186	11,609	-132,000
Net Income	-14,987,549	11,262,000	-1,943,000	-805,000
Per Share
EPS	-4.41	189.00	-221.40	-0.61
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Bionomics Limited (BNOX).
Income Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2023-06-29	2022-06-30
Revenue	23,953,671	0	432,666	20,000	4,180,697
Cost of Revenue	1,014,645	992,563	13,063,320	13,063,320	11,045,981
Gross Profit	22,939,025	-992,563	-12,630,654	-12,630,654	-6,865,284
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	10,883,695	11,694,746	5,898,843	8,860,000	5,289,226
Operating Expenses	24,667,256	25,794,112	9,023,932	32,000,000	8,278,435
Operating Income	-1,728,231	-26,786,676	-18,529,498	-31,970,000	-12,149,902
Interest Expense	0	0	21,278	20,000	0
Income Before Tax	-1,282,673	-23,324,048	-21,349,240	-32,050,000	-15,155,458
Income Tax Expense	-716,899	-130,726	137,732	-210,000	132,427
Net Income	-565,773	-23,193,321	-21,211,507	-31,850,000	-15,023,030
Per Share
EPS	-0.23	-0.10	-2.60	-0.02	-2.49
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Bionomics Limited (BNOX).
Balance Sheet (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Assets
Cash and Cash Equivalents	14,210,745,000	12,608,109	12,155,491	23,173,748
Short Term Investments	0	0	0	0
Net Receivables	11,948,000	126,884	427,789	4,665,231
Inventory	0	0	-427,789	-4,665,230
Total Current Assets	15,040,831,000	13,193,758	13,384,671	28,866,505
Property Plant Equipment	105,383,000	218,969	334,529	465,706
Goodwill and Intangibles	13,443,400,000	14,157,540	14,844,073	15,676,881
Total Assets	28,589,614,000	27,649,093	28,642,534	45,091,253
Liabilities
Account Payables	1,154,369,000	2,243,662	1,373,750	1,074,897
Short Term Debt	116,314,000	121,990	114,385	110,051
Total Current Liabilities	4,220,760,000	3,829,073	2,750,329	2,316,790
Long Term Debt	0	117,628	361,742	0
Total Liabilities	9,587,040,000	10,158,721	6,564,568	5,797,651
Shareholders Equity
Retained Earnings	-178,346,703,000	-177,977,071	-136,386,405	-119,653,757
Total Shareholders Equity	19,002,574,000	17,490,372	22,077,966	39,293,602

Balance sheet annual history for Bionomics Limited (BNOX).
Balance Sheet (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Assets
Cash and Cash Equivalents	14,210,745,000	12,608,109	12,155,491	23,173,748	28,499,449
Short Term Investments	0	0	0	0	435,640
Net Receivables	11,948,000	126,884	427,789	4,665,231	200,212
Inventory	0	0	-427,789	-4,665,230	0
Total Current Assets	15,040,831,000	13,193,758	13,384,671	28,866,505	30,927,004
Property Plant Equipment	105,383,000	218,969	334,529	465,706	870,943
Goodwill and Intangibles	13,443,400,000	14,157,540	14,844,073	15,676,881	22,346,498
Total Assets	28,589,614,000	27,649,093	28,642,534	45,091,253	54,263,445
Liabilities
Account Payables	1,154,369,000	2,243,662	1,373,750	1,074,897	1,028,744
Short Term Debt	116,314,000	121,990	114,385	110,051	174,218
Total Current Liabilities	4,220,760,000	3,829,073	2,750,329	2,316,790	2,360,544
Long Term Debt	0	117,628	361,742	0	693,623
Total Liabilities	9,587,040,000	10,158,721	6,564,568	5,797,651	6,665,908
Shareholders Equity
Retained Earnings	-178,346,703,000	-177,977,071	-136,386,405	-119,653,757	-154,040,501
Total Shareholders Equity	19,002,574,000	17,490,372	22,077,966	39,293,602	47,597,537

Cash flow quarterly history for Bionomics Limited (BNOX).
Cash Flow Statement (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Operating Activities
Net Income	-369,632,000	-15,492,166	-21,211,507	-15,023,030
Depreciation & Amortization	662,890,000	662,991	770,608	765,956
Stock Based Compensation	163,772,000	814,808	1,904,553	1,953,665
Change in Working Capital	-496,826	1,454,857	33,063	-27,028
Operating Cash Flow	77,229,000	-14,680,777	-14,215,644	-15,020,358
Investing Activities
Capital Expenditure	0	-4	0	-1,066
Investments	0	-4	0	-1,066
Investing Cash Flow	0	0	319,387	429,234
Financing Activities
Debt Repayment	0	0	-106,593	-120,283
Common Stock Issued/Repurchased	1,528,276	10,111,979	3,845,462	19,703,327
Dividends Paid	0	0	0	0
Financing Cash Flow	1,528,276,000	15,108,794	3,701,120	18,638,236
Summary
Free Cash Flow	77,229,000	-14,680,781	-14,215,644	-15,021,424
Net Change in Cash	1,601,755,000	504,991	-11,018,257	1,803,436

Cash flow annual history for Bionomics Limited (BNOX).
Cash Flow Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Operating Activities
Net Income	-369,632,000	-15,492,166	-21,211,507	-15,023,030	-8,697,037
Depreciation & Amortization	662,890,000	662,991	770,608	765,956	0
Stock Based Compensation	163,772,000	814,808	1,904,553	1,953,665	0
Change in Working Capital	-496,826	1,454,857	33,063	-27,028	0
Operating Cash Flow	77,229,000	-14,680,777	-14,215,644	-15,020,358	0
Investing Activities
Capital Expenditure	0	-4	0	-1,066	-1,468
Investments	0	-4	0	-1,066	-1,468
Investing Cash Flow	0	0	319,387	429,234	-80,206
Financing Activities
Debt Repayment	0	0	-106,593	-120,283	-11,087,139
Common Stock Issued/Repurchased	1,528,276	10,111,979	3,845,462	19,703,327	43,420,652
Dividends Paid	0	0	0	0	0
Financing Cash Flow	1,528,276,000	15,108,794	3,701,120	18,638,236	31,553,706
Summary
Free Cash Flow	77,229,000	-14,680,781	-14,215,644	-15,021,424	-7,540,192
Net Change in Cash	1,601,755,000	504,991	-11,018,257	1,803,436	23,921,702